Literature DB >> 10398078

The transition from hyperplasia to invasive carcinoma of the breast.

S R Lakhani1.   

Abstract

The multistep model of carcinogenesis in the breast suggests a transition from normal epithelium to invasive carcinoma via non-atypical and atypical hyperplasia and in situ carcinoma. Within the breast, these proliferations are heterogeneous in their cytological and architectural characteristics. This review considers the evidence supporting a precursor role for these preinvasive lesions.

Entities:  

Mesh：

Year:  1999        PMID： 10398078     DOI： 10.1002/(SICI)1096-9896(199902)187:3<272::AID-PATH265>3.0.CO;2-2

Source DB:  PubMed          Journal:  J Pathol        ISSN： 0022-3417            Impact factor:   7.996


  42 in total

1.  Precancerous Lesions of the Breast.

Authors:  Annette Lebeau
Journal:  Breast Care (Basel)       Date:  2010-08-03       Impact factor: 2.860

2.  What is the sensitivity of mammography and dynamic MR imaging for DCIS if the whole-breast histopathology is used as a reference standard?

Authors:  F Sardanelli; L Bacigalupo; L Carbonaro; A Esseridou; G M Giuseppetti; P Panizza; V Lattanzio; A Del Maschio
Journal:  Radiol Med       Date:  2008-07-09       Impact factor: 3.469

3.  [The significance of "normal tissue" in the development of breast cancer: new concepts of early carcinogenesis].

Authors:  H Bürger; C Kersting; D Hungermann; T Decker; W Böcker
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

4.  [Prognostic factors in ductal carcinoma in situ].

Authors:  A Lebeau
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

5.  A multistage association study identifies a breast cancer genetic locus at NCOA7.

Authors:  Kathryn S P Higginbotham; Joan P Breyer; Kevin M Bradley; Peggy A Schuyler; W Dale Plummer; Marcia E Freudenthal; Amy Trentham-Dietz; Polly A Newcomb; Melinda E Sanders; David L Page; Fritz F Parl; Kathleen M Egan; William D Dupont; Jeffrey R Smith
Journal:  Cancer Res       Date:  2011-05-24       Impact factor: 12.701

6.  Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

7.  A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease.

Authors:  Thomas E Rohan; Abdissa Negassa; Rowan T Chlebowski; Clementina D Ceria-Ulep; Barbara B Cochrane; Dorothy S Lane; Mindy Ginsberg; Sylvia Wassertheil-Smoller; David L Page
Journal:  Breast Cancer Res Treat       Date:  2008-10-14       Impact factor: 4.872

8.  Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas.

Authors:  Pamela S Larson; Antonio de las Morenas; Sheila R Bennett; L Adrienne Cupples; Carol L Rosenberg
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

9.  Short-term prophylactic tamoxifen reduces the incidence of antiestrogen-resistant/estrogen receptor-positive/progesterone receptor-negative mammary tumors.

Authors:  Teresa A Rose-Hellekant; Andrew J Skildum; Olga Zhdankin; Amy L Greene; Ronald R Regal; Katherine D Kundel; Donald W Kundel
Journal:  Cancer Prev Res (Phila)       Date:  2009-04-28

10.  Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.

Authors:  Elaine Y Lin; Joan G Jones; Ping Li; Liyin Zhu; Kathleen D Whitney; William J Muller; Jeffrey W Pollard
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.